Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Interleukin-15 as an activator of natural killer cell-mediated antiviral response.

Gosselin J, TomoIu A, Gallo RC, Flamand L.

Blood. 1999 Dec 15;94(12):4210-9.

2.

Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.

Reiter Z.

Crit Rev Immunol. 1993;13(1):1-34. Review. Erratum in: Crit Rev Immunol 1993;13(2):193.

PMID:
8466640
3.
4.

Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15.

Flamand L, Stefanescu I, Menezes J.

J Clin Invest. 1996 Mar 15;97(6):1373-81.

6.

Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study.

Fawaz LM, Sharif-Askari E, Menezes J.

J Immunol. 1999 Oct 15;163(8):4473-80.

7.

Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.

Loubeau M, Ahmad A, Toma E, Menezes J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 1;16(3):137-45.

PMID:
9390564
9.

Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction.

Atedzoe BN, Ahmad A, Menezes J.

J Immunol. 1997 Nov 15;159(10):4966-72.

PMID:
9366423
10.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976
11.

Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.

Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH.

J Immunol. 1986 May 15;136(10):3636-42.

PMID:
3009608
12.

Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.

Paya CV, Schoon RA, Leibson PJ.

J Immunol. 1990 Jun 1;144(11):4370-5.

PMID:
2160501
13.

Natural killer (NK) cells prevent virus production in cell culture.

Baraz L, Khazanov E, Condiotti R, Kotler M, Nagler A.

Bone Marrow Transplant. 1999 Jul;24(2):179-89.

14.

Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.

Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL, Ritz J.

J Immunol. 1987 Nov 15;139(10):3306-13.

PMID:
2824604
15.

Defective NK cell activity following thermal injury.

Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD.

Clin Exp Immunol. 1986 Nov;66(2):384-92.

16.

In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.

Tanaka-Kataoka M, Kunikata T, Takayama S, Iwaki K, Ohashi K, Ikeda M, Kurimoto M.

Cytokine. 1999 Aug;11(8):593-9.

PMID:
10433806
17.
18.

The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.

de Rham C, Ferrari-Lacraz S, Jendly S, Schneiter G, Dayer JM, Villard J.

Arthritis Res Ther. 2007;9(6):R125.

19.

IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes.

Costa P, Sivori S, Bozzano F, Martini I, Moretta A, Moretta L, De Maria A.

Eur J Immunol. 2009 Jan;39(1):147-58. doi: 10.1002/eji.200838532. Erratum in: Eur J Immunol. 2009 Mar;39(3):912.

20.

Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.

Fitzgerald PA, Mendelsohn M, Lopez C.

J Immunol. 1985 Apr;134(4):2666-72.

PMID:
2982949

Supplemental Content

Support Center